1. Home
  2. AQMS vs ABP Comparison

AQMS vs ABP Comparison

Compare AQMS & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$8.05

Market Cap

21.2M

Sector

Industrials

ML Signal

HOLD

ABP

Abpro Holdings Inc Common Stock

HOLD

Current Price

$6.36

Market Cap

18.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQMS
ABP
Founded
2014
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
18.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
AQMS
ABP
Price
$8.05
$6.36
Analyst Decision
Buy
Hold
Analyst Count
1
1
Target Price
$12.00
N/A
AVG Volume (30 Days)
260.6K
192.6K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$550.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.00
52 Week Low
$3.37
$4.55
52 Week High
$39.40
$153.90

Technical Indicators

Market Signals
Indicator
AQMS
ABP
Relative Strength Index (RSI) 52.14 75.54
Support Level $7.25 $6.31
Resistance Level $8.28 $7.02
Average True Range (ATR) 0.79 0.47
MACD 0.16 -0.16
Stochastic Oscillator 84.62 51.00

Price Performance

Historical Comparison
AQMS
ABP

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: